115 related articles for article (PubMed ID: 38079224)
1. Asperosaponin VI facilitates the regeneration of skeletal muscle injury by suppressing GSK-3β-mediated cell apoptosis.
Yang X; Liang J; Shu Y; Wei L; Wen C; Luo H; Ma L; Qin T; Wang B; Zeng S; Liu Y; Zhou C
J Cell Biochem; 2024 Jan; 125(1):115-126. PubMed ID: 38079224
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism.
Theeuwes WF; Gosker HR; Langen RCJ; Verhees KJP; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3075-3086. PubMed ID: 28943449
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PGC-1α expression by a GSK-3β-TFEB signaling axis in skeletal muscle.
Theeuwes WF; Gosker HR; Schols AMWJ; Langen RCJ; Remels AHV
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118610. PubMed ID: 31738957
[TBL] [Abstract][Full Text] [Related]
4. Curcumin ameliorates CKD-induced mitochondrial dysfunction and oxidative stress through inhibiting GSK-3β activity.
Wang D; Yang Y; Zou X; Zheng Z; Zhang J
J Nutr Biochem; 2020 Sep; 83():108404. PubMed ID: 32531667
[TBL] [Abstract][Full Text] [Related]
5. iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3β activation in skeletal muscle of rats.
Kaneki M; Fukushima Y; Shinozaki S; Fukaya M; Habiro M; Shimizu N; Chang K; Yasuhara S; Martyn JA
Metabolism; 2013 Mar; 62(3):341-6. PubMed ID: 22995863
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis.
Theeuwes WF; Gosker HR; Langen RCJ; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2913-2926. PubMed ID: 29883716
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.
Pansters NA; Schols AM; Verhees KJ; de Theije CC; Snepvangers FJ; Kelders MC; Ubags ND; Haegens A; Langen RC
Biochim Biophys Acta; 2015 Mar; 1852(3):490-506. PubMed ID: 25496993
[TBL] [Abstract][Full Text] [Related]
8. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death.
Lin CJ; Chen TH; Yang LY; Shih CM
Cell Death Dis; 2014 Mar; 5(3):e1147. PubMed ID: 24675465
[TBL] [Abstract][Full Text] [Related]
10. GSK-3beta activity is increased in skeletal muscle after burn injury in rats.
Fang CH; Li B; James JH; Yahya A; Kadeer N; Guo X; Xiao C; Supp DM; Kagan RJ; Hasselgren PO; Sheriff S
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1545-51. PubMed ID: 17686886
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
12. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.
Kitazawa M; Trinh DN; LaFerla FM
Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434
[TBL] [Abstract][Full Text] [Related]
13. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
15. Hastatoside attenuatescarbon tetrachloride-induced liver fibrosis by targeting glycogen synthase kinase-3β.
Du C; Dong J; Wang Q; Xu C; Feng S; Feng R; Lv X; Li J; Zhang L; Huang C; Ma T
Phytomedicine; 2023 Jan; 109():154585. PubMed ID: 36610117
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
17. Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway.
Aschenbach WG; Ho RC; Sakamoto K; Fujii N; Li Y; Kim YB; Hirshman MF; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E152-8. PubMed ID: 16478782
[TBL] [Abstract][Full Text] [Related]
18. Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.
Wang Y; Hao Y; Alway SE
J Cell Sci; 2011 Nov; 124(Pt 22):3835-47. PubMed ID: 22114306
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.
van der Velden JLJ; Schols AMWJ; Willems J; Kelders MCJM; Langen RCJ
J Biol Chem; 2008 Jan; 283(1):358-366. PubMed ID: 17977834
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
